Arizona State Retirement System Raises Position in Mesa Laboratories, Inc. (NASDAQ:MLAB)

Arizona State Retirement System grew its position in Mesa Laboratories, Inc. (NASDAQ:MLAB – Get Rating) by 4.8% in the 4th quarter, Holdings Channel reports. The institutional investor owned 1,500 shares of the medical instruments supplier’s stock after purchasing an additional 69 shares during the quarter. Arizona State Retirement System’s holdings in Mesa Laboratories were worth $249,000 as of its most recent SEC filing.

Several other large investors have also bought and sold shares of the company. Geneva Capital Management LLC raised its holdings in Mesa Laboratories by 83.1% in the fourth quarter. Geneva Capital Management LLC now owns 191,816 shares of the medical instruments supplier’s stock worth $31,882,000 after buying an additional 87,031 shares during the last quarter. LPL Financial LLC purchased a new position in Mesa Laboratories in the fourth quarter worth about $250,000. Envestnet Asset Management Inc. raised its holdings in Mesa Laboratories by 11.8% in the fourth quarter. Envestnet Asset Management Inc. now owns 12,597 shares of the medical instruments supplier’s stock worth $2,094,000 after buying an additional 1,327 shares during the last quarter. Cutter & CO Brokerage Inc. purchased a new position in Mesa Laboratories in the fourth quarter worth about $232,000. Finally, CWM LLC raised its holdings in shares of Mesa Laboratories by 116.7% during the fourth quarter. CWM LLC now owns 156 shares of the medical instruments supplier’s stock valued at $26,000 after purchasing an additional 84 shares during the last quarter. 93.00% of the stock is owned by hedge funds and other institutional investors.

Insider Activity

In other Mesa Laboratories news, CFO John Sakys sold 1,000 shares of the company’s stock in a transaction that occurred on Wednesday, March 15th. The shares were sold at an average price of $165.71, for a total transaction of $165,710.00. Following the completion of the sale, the chief financial officer now directly owns 9,696 shares of the company’s stock, valued at $1,606,724.16. The sale was disclosed in a filing with the SEC, which can be accessed through this link. Insiders sold 6,028 shares of company stock valued at $1,018,145 over the last three months. Insiders own 5.50% of the company’s stock.

Wall Street Analysts Forecast Growth

Separately, StockNews.com assumed coverage on shares of Mesa Laboratories in a report on Thursday, May 18th. They set a “hold” rating for the company.

Mesa Laboratories Stock Down 1.0 %

MLAB opened at $155.47 on Wednesday. The company has a quick ratio of 1.93, a current ratio of 2.74 and a debt-to-equity ratio of 0.49. The firm has a 50 day moving average price of $167.44 and a 200-day moving average price of $173.80. Mesa Laboratories, Inc. has a twelve month low of $114.21 and a twelve month high of $226.40. The stock has a market capitalization of $831.14 million, a price-to-earnings ratio of -536.10 and a beta of 0.73.

Mesa Laboratories Announces Dividend

The business also recently disclosed a quarterly dividend, which will be paid on Thursday, June 15th. Stockholders of record on Wednesday, May 31st will be issued a dividend of $0.16 per share. The ex-dividend date of this dividend is Tuesday, May 30th. This represents a $0.64 annualized dividend and a dividend yield of 0.41%. Mesa Laboratories’s payout ratio is -220.69%.

Mesa Laboratories Company Profile

(Get Rating)

Mesa Laboratories, Inc engages in the design, manufacture, and market of instruments and disposable products utilized in healthcare, pharmaceutical, food and beverage, medical device, and petrochemical industries. It operates through the following segments: Sterilization and Disinfection Control, Instruments, Continuous Monitoring, and Biopharmaceutical Development.